The site is undergoing maintenance on
Thursday, September 10, 2026, 12:00 - 8:00 pm (EDT).
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 2026, 12:00 - 8:00 pm (EDT).
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 2026, 12:00 - 8:00 pm (EDT)
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Multiparameter flow cytometric analysis of TIM-3 (CD366) expression on human peripheral blood leucocytes. Human whole blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either BD Horizon™ BV650 Mouse IgG1 κ Isotype Control (Cat. No. 563231; Top Panels) or BD Horizon BV650 Mouse Anti-Human TIM-3 (CD366) antibody (Cat. No. 565564/565565; Bottom Panels). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Left Panels - Two-parameter flow cytometric dot plots showing the correlated expression of TIM-3 (CD366) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals were derived from gated events with the forward and side light-scatter characteristics of intact leucocyte populations.
Right Panels - The two-color flow cytometric dot plots showing the correlated expression of TIM-3 (CD366) [or Ig Isotype control staining] versus CD56 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes.
Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multiparameter flow cytometric analysis of TIM-3 (CD366) expression on human peripheral blood leucocytes. Human whole blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either BD Horizon™ BV650 Mouse IgG1 κ Isotype Control (Cat. No. 563231; Top Panels) or BD Horizon BV650 Mouse Anti-Human TIM-3 (CD366) antibody (Cat. No. 565564/565565; Bottom Panels). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Left Panels - Two-parameter flow cytometric dot plots showing the correlated expression of TIM-3 (CD366) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals were derived from gated events with the forward and side light-scatter characteristics of intact leucocyte populations.
Right Panels - The two-color flow cytometric dot plots showing the correlated expression of TIM-3 (CD366) [or Ig Isotype control staining] versus CD56 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes.
Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Multiparameter flow cytometric analysis of TIM-3 (CD366) expression on human peripheral blood leucocytes. Human whole blood was stained with FITC Mouse Anti-Human CD56 antibody (Cat. No. 562794) and either BD Horizon™ BV650 Mouse IgG1 κ Isotype Control (Cat. No. 563231; Top Panels) or BD Horizon BV650 Mouse Anti-Human TIM-3 (CD366) antibody (Cat. No. 565564/565565; Bottom Panels). Erythrocytes were lysed with BD FACS Lysing Solution (Cat. No. 349202).
Left Panels - Two-parameter flow cytometric dot plots showing the correlated expression of TIM-3 (CD366) [or Ig Isotype control staining] versus side light-scatter (SSC-A) signals were derived from gated events with the forward and side light-scatter characteristics of intact leucocyte populations.
Right Panels - The two-color flow cytometric dot plots showing the correlated expression of TIM-3 (CD366) [or Ig Isotype control staining] versus CD56 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes.
Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 7D3 monoclonal antibody specifically binds to T cell immunoglobulin mucin 3 (TIM-3) which is also known as, CD366, or T-cell immunoglobulin and mucin domain-containing protein 3 (TIMD-3/TIMD3). CD366 is encoded by the HAVCR2 gene (Hepatitis A virus cellular receptor 2). CD366 is a type I transmembrane glycoprotein and belongs to the human TIM family (along with TIM-1 and TIM-4) within the immunoglobulin superfamily. CD366 is expressed on Th1, Tc1, Th17, Treg, NK T, and NK cells. CD366 is also expressed on dendritic cells, mast cells, monocytes, and macrophages. It is not expressed by Th2 and B cells. CD366 helps maintain peripheral immune tolerance and homeostasis. CD366 regulates macrophage activation and is a negative regulator of Th1 cell function. Crosslinking of cell surface CD366 by binding to Galectin-9 and/or phosphatidylserine appears to play an important role in either positively or negatively regulating leucocyte functions, such as cytokine production or the phagocytosis of apoptotic cells. CD366 may also be useful as an AML stem cell surface marker because it appears to be more highly expressed by AML leukemia stem cells than by normal bone marrow hematopoietic stem cells.
The antibody was conjugated to BD Horizon BV650 which is part of the BD Horizon Brilliant™ Violet family of dyes. This dye is a tandem fluorochrome of BD Horizon BV421 with an Ex Max of 405-nm and an acceptor dye with an Em Max at 650-nm. BD Horizon BV650 can be excited by the violet laser and detected in a filter used to detect APC-like dyes (eg, 660/20-nm filter). Due to the excitation and emission characteristics of the acceptor dye, there will be spillover into the APC and Alexa Fluor® 700 detectors. However, the spillover can be corrected through compensation as with any other dye combination.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.